Related Experiment Video

Updated: May 27, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis

Chunmei Li1, Wanglin Jiang, Haibo Zhu

  • 1School of pharmacy, Yantai University, PR China.

Pharmaceutical Biology
|December 2, 2011
PubMed
Abstract

Insights

Protocatechuic aldehyde (PA) was investigated for its antifibrotic effects. PA demonstrated significant inhibition of liver fibrosis in vitro and in vivo by reducing key fibrotic markers.

Area of Science:

  • Hepatology and Pharmacology
  • Biochemistry and Molecular Biology

Background:

  • Liver fibrosis is linked to transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF).
  • Protocatechuic aldehyde (PA) is a phenolic acid derivative with potential therapeutic properties.

Purpose of the Study:

  • To evaluate the antifibrotic potential of PA in experimental liver fibrosis.
  • To elucidate the underlying mechanisms of PA's antifibrotic action.

Main Methods:

  • Assessed PA's effect on hepatic stellate cell (HSC) proliferation and collagen production in vitro.
  • Utilized a carbon tetrachloride (CCl4)-induced rat liver fibrosis model to evaluate PA's in vivo efficacy.
  • Measured fibrotic markers (TGF-β1, CTGF, collagen I/III) using ELISA, Western blot, and histopathology.

Main Results:

  • PA inhibited HSC proliferation and reduced TGF-β1, CTGF, and collagen levels in vitro.
  • PA treatment significantly decreased liver fibrosis grade, improved biochemical indicators, and ameliorated histopathological changes in rats.
  • PA reduced hepatic expression of TGF-β1 and CTGF in the fibrotic rat livers.

Conclusions:

  • Protocatechuic aldehyde exhibits significant antifibrotic effects.
  • PA demonstrates potential as a therapeutic agent for liver fibrosis.

More Related Videos

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...